Brown Brothers Harriman & Co’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $74M | Sell |
206,212
-22,203
| -10% | -$6.79M | 0.32% | 61 |
|
|
2026
Q1 | $57.2M | Sell |
228,415
-12,276
| -5% | -$3.05M | 0.31% | 71 |
|
|
2025
Q4 | $66.2M | Sell |
240,691
-6,665
| -3% | -$1.82M | 0.36% | 59 |
|
|
2025
Q3 | $64.9M | Buy |
247,356
+44,938
| +22% | +$10.9M | 0.4% | 52 |
|
|
2025
Q2 | $44.3M | Buy |
202,418
+51,747
| +34% | +$11.1M | 0.28% | 71 |
|
|
2025
Q1 | $33.7M | Buy |
150,671
+55,683
| +59% | +$15.3M | 0.24% | 75 |
|
|
2024
Q4 | $31.1M | Buy |
+94,988
| New | +$29.9M | 0.22% | 72 |
|
|
2024
Q1 | – | Sell |
-87
| Closed | -$30.6K | – | 1277 |
|
|
2023
Q4 | $30.6K | Sell |
87
-26
| -23% | -$9.2K | ﹤0.01% | 787 |
|
|
2023
Q3 | $42.4K | Hold |
113
| – | – | ﹤0.01% | 731 |
|
|
2023
Q2 | $43.2K | Sell |
113
-57
| -34% | -$20.4K | ﹤0.01% | 740 |
|
|
2023
Q1 | $58.9K | Buy |
170
+7
| +4% | +$2.04K | ﹤0.01% | 710 |
|
|
2022
Q4 | $38.4K | Hold |
163
| – | – | ﹤0.01% | 764 |
|
|
2022
Q3 | $40K | Sell |
163
-12
| -7% | -$3.66K | ﹤0.01% | 788 |
|
|
2022
Q2 | $53K | Buy |
175
+19
| +12% | +$6.18K | ﹤0.01% | 692 |
|
|
2022
Q1 | $64K | Hold |
156
| – | – | ﹤0.01% | 721 |
|
|
2021
Q4 | $73K | Buy |
156
+57
| +58% | +$24.5K | ﹤0.01% | 642 |
|
|
2021
Q3 | $42K | Hold |
99
| – | – | ﹤0.01% | 711 |
|
|
2021
Q2 | $36K | Hold |
99
| – | – | ﹤0.01% | 727 |
|
|
2021
Q1 | $28K | Buy |
99
+12
| +14% | +$3.43K | ﹤0.01% | 738 |
|
|
2020
Q4 | $25K | Hold |
87
| – | – | ﹤0.01% | 762 |
|
|
2020
Q3 | $24K | Hold |
87
| – | – | ﹤0.01% | 673 |
|
|
2020
Q2 | $20K | Hold |
87
| – | – | ﹤0.01% | 688 |
|
|
2020
Q1 | $13K | Sell |
87
-30
| -26% | -$4.62K | ﹤0.01% | 679 |
|
|
2019
Q4 | $18K | Hold |
117
| – | – | ﹤0.01% | 815 |
|
|
2019
Q3 | $17K | Buy |
117
+87
| +290% | +$12K | ﹤0.01% | 823 |
|
|
2019
Q2 | $4K | Buy |
+30
| New | +$3.54K | ﹤0.01% | 923 |
|
|
2019
Q1 | – | Sell |
-60
| Closed | -$6K | – | 1124 |
|
|
2018
Q4 | $6K | Hold |
60
| – | – | ﹤0.01% | 772 |
|
|
2018
Q3 | $7K | Hold |
60
| – | – | ﹤0.01% | 728 |
|
|
2018
Q2 | $6K | Buy |
+60
| New | +$5.52K | ﹤0.01% | 726 |
|
|
2018
Q1 | – | Sell |
-20
| Closed | -$2K | – | 1150 |
|
|
2017
Q4 | $2K | Buy |
+20
| New | +$1.96K | ﹤0.01% | 1072 |
|
|
2017
Q3 | – | Sell |
-111
| Closed | -$10K | – | 783 |
|
|
2017
Q2 | $10K | Hold |
111
| – | – | ﹤0.01% | 660 |
|
|
2017
Q1 | $9K | Hold |
111
| – | – | ﹤0.01% | 669 |
|
|
2016
Q4 | $9K | Hold |
111
| – | – | ﹤0.01% | 715 |
|
|
2016
Q3 | $8K | Hold |
111
| – | – | ﹤0.01% | 644 |
|
|
2016
Q2 | $8K | Buy |
+111
| New | +$8.08K | ﹤0.01% | 661 |
|
|
2013
Q3 | – | Sell |
-2,400
| Closed | -$84K | – | 801 |
|
|
2013
Q2 | $84K | Buy |
+2,400
| New | +$79K | ﹤0.01% | 483 |
|
Other funds holding WST
GIM
Brown Brothers Harriman & Co's WST Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its West Pharmaceutical (WST) stake by 9.7% in Q2 2026, selling an estimated $6.79M and leaving 206,212 shares worth $74M. The position accounts for 0.32% of the portfolio, ranked #61.
Brown Brothers Harriman & Co first reported a position in WST in Q2 2013 and has held it in 36 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Brown Brothers Harriman & Co held 206,212 shares of West Pharmaceutical worth $74M as of Q2 2026.
- Brown Brothers Harriman & Co sold 22,203 West Pharmaceutical shares in Q2 2026, an estimated $6.79M.
- West Pharmaceutical made up 0.32% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #61 holding.
- Brown Brothers Harriman & Co first reported a position in West Pharmaceutical in Q2 2013 and has held it in 36 quarters since.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.